Showing results (331-340 of 365) with videos related to

Sort By:
Pageof 37
Elife|January 25, 2022
Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccinationGeorge Elias, Pieter Meysman, Esther Bartholomeus, et al.
Cancer Epidemiology|February 21, 2016
Surveillance of effects of HPV vaccination in BelgiumMarc Arbyn, Davy Vanden Broeck, Ina Benoy, et al.
The Journal of Infectious Diseases|October 3, 2023
Diagnosing Viral Infections Through T-Cell Receptor Sequencing of Activated CD8+ T CellsAlexandra Vujkovic, My Ha, Tessa de Block, et al.
The Lancet. Infectious Diseases|April 24, 2022
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trialNicolas Folschweiller, Carline Vanden Abeele, Laurence Chu, et al.
Vaccine|June 29, 2026
Protocol for a phase 3, randomized, double-blind clinical trial evaluating the safety and immunogenicity of the MVA-BN® vaccine against mpox in children aged 4 to less than 24 months in the Democratic Republic of the Congo: Data to guide future paediatric vaccination strategiesSolange Milolo Tshilumba, Paulina Morales Ruiz, Trésor Zola Matuvanga, et al.
Vaccine|February 6, 2023
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized studyRahsan Erdem, Ilse De Coster, Kanchanamala Withanage, et al.
NPJ Vaccines|July 30, 2021
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine virusesRahnuma Wahid, Laina Mercer, Andrew Macadam, et al.
The Lancet. Infectious Diseases|May 14, 2021
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trialTimo Vesikari, Joanne M Langley, Nathan Segall, et al.
Vaccine|October 19, 2019
Vaccination of healthcare personnel in Europe: Update to current policiesHelena C Maltezou, Elisabeth Botelho-Nevers, Arne B Brantsæter, et al.
The Lancet. Infectious Diseases|January 26, 2026
Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trialIlse De Coster, Mohammad AbdelGhany, Eleanna Sarakinou, et al.
Pageof 37